Valsts: Lielbritānija
Valoda: angļu
Klimata pārmaiņas: VMD (Veterinary Medicines Directorate)
Ceftiofur
Virbac S.A.
QJ01DA90
Ceftiofur
Expired
Issued: October 2012 AN: 01470/2008 SUMMARY OF THE PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT VIRBACEF STERILE POWDER FOR INJECTION FOR CATTLE, PIGS AND HORSES 2. QUALITATIVE AND QUANTITATIVE COMPOSITION ACTIVE SUBSTANCE: Each vial contains 1 g or 4 g of ceftiofur as ceftiofur sodium. For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Powder for solution for injection. White-to-beige (yellowish) amorphous powder. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle, pigs, horses. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES CATTLE Treatment of cattle with acute bacterial respiratory disease in which _Mannheimia_ _haemolytica_, _Pasteurella multocida_, _Histophilus somni_ or other sensitive bacterial pathogens of the respiratory tract are involved. Treatment of cattle with acute interdigital necrobacillosis (foul in the foot) in which _Fusobacterium necrophorum_ and _Bacteroides melaninogenicus_ are involved. As with all antibiotic therapy, treatment of this condition with the product should be instituted as early as possible in order to provide maximum clinical effect. PIGS Treatment of pigs with bacterial respiratory disease in which _Actinobacillus_ _(Haemophilus) pleuropneumoniae_, _Pasteurella multocida_ and/or _Streptococcus_ _suis_ are involved. HORSES Treatment of horses with bacterial respiratory disease in which _Streptococcus _spp. including _Streptococcus zooepidermicus_ and _Streptococcus equi_, _Staphylococcus_ spp. and/or _Pasteurella _spp._ _are involved. Pa Izlasiet visu dokumentu